Yunjiao Yang Selected Research

Yunjiao Yang Research Topics

Disease

8	Takayasu Arteritis (Arteritis, Takayasu's) 04/2024 - 12/2016
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 01/2022
3	Infections 01/2024 - 03/2017
3	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 01/2018
3	Inflammation (Inflammations) 02/2023 - 03/2017
3	Insulin Resistance 01/2023 - 01/2018
2	Central Nervous System Lupus Vasculitis 04/2023 - 01/2023
2	Fever (Fevers) 03/2023 - 01/2020
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2018
2	Diabetes Mellitus 01/2022 - 01/2018
2	Immunoglobulin G4-Related Disease 01/2021 - 11/2015
2	Arthritis (Polyarthritis) 11/2019 - 04/2013
1	Liver Diseases (Liver Disease) 03/2024
1	Systemic Vasculitis 01/2024
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2023
1	Rheumatic Diseases (Rheumatism) 07/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2023
1	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2023
1	Diabetic Cardiomyopathies 05/2023
1	Ischemic Stroke 05/2023
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 03/2023
1	Stroke (Strokes) 03/2023
1	Atherosclerosis 02/2023
1	Virus Diseases (Viral Diseases) 02/2023
1	Body Weight (Weight, Body) 01/2023
1	Aneurysm (Aneurysms) 01/2023
1	Pulmonary Hypertension 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Dementia (Dementias) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Cognitive Dysfunction 01/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022
1	Renal Artery Obstruction (Renal Artery Stenosis) 01/2022
1	Hypertriglyceridemia 01/2022
1	Uveitis 11/2019

Drug/Important Bio-Agent (IBA)

6	C-Reactive ProteinIBA 03/2023 - 03/2017
3	Interleukin-6 (Interleukin 6)IBA 04/2024 - 12/2020
3	Methotrexate (Mexate)FDA LinkGeneric 04/2023 - 11/2019
3	Immunosuppressive Agents (Immunosuppressants)IBA 03/2023 - 11/2015
3	GlucocorticoidsIBA 02/2023 - 11/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 12/2020
3	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2018
2	tocilizumab (atlizumab)FDA Link 04/2024 - 03/2017
2	LipidsIBA 01/2024 - 01/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2023 - 01/2023
2	Immunoglobulin G (IgG)IBA 02/2023 - 01/2021
2	CholesterolIBA 01/2023 - 01/2022
2	Malondialdehyde (Propanedial)IBA 01/2023 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2020
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2018
2	AlbuminsIBA 01/2022 - 01/2018
2	Insulin (Novolin)FDA Link 01/2022 - 01/2022
2	Complement System Proteins (Complement)IBA 01/2021 - 04/2013
1	baricitinibIBA 03/2024
1	InterferonsIBA 01/2024
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2024
1	oxidized low density lipoproteinIBA 01/2024
1	Lipoproteins (Lipoprotein)IBA 01/2024
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2024
1	IDL Lipoproteins (Lipoprotein, IDL)IBA 01/2024
1	Rituximab (Mabthera)FDA Link 09/2023
1	Inosine Triphosphate (ITP)IBA 07/2023
1	InflammasomesIBA 05/2023
1	GinsenosidesIBA 05/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2023
1	LectinsIBA 02/2023
1	Polysaccharides (Glycans)IBA 02/2023
1	Antirheumatic Agents (DMARD)IBA 02/2023
1	Leflunomide (Arava)FDA LinkGeneric 02/2023
1	AntibodiesIBA 02/2023
1	LDL CholesterolIBA 01/2023
1	vasectrin I (VS I)IBA 01/2023
1	Superoxide DismutaseIBA 01/2023
1	Tumor Necrosis Factor InhibitorsIBA 01/2023
1	Methylprednisolone FDA LinkGeneric 01/2023
1	Glutathione PeroxidaseIBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	Nonesterified Fatty Acids (NEFA)IBA 01/2023
1	CatalaseIBA 01/2023
1	HDL CholesterolIBA 01/2023
1	secukinumabIBA 01/2023
1	Ribonucleases (Ribonuclease)IBA 11/2022
1	Hydroxyl RadicalIBA 01/2022
1	CreatinineIBA 01/2022
1	AntioxidantsIBA 01/2022
1	NitrogenIBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Fenofibrate (CiL)FDA LinkGeneric 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	safflower yellowIBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020

Therapy/Procedure

6	Therapeutics 01/2024 - 03/2017
2	Spinal Injections 04/2023 - 01/2023